PubRank

F Patrone

Author PubWeight™ 51.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Proteasome inhibitors: antitumor effects and beyond. Leukemia 2006 1.87
2 Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. J Natl Cancer Inst 1984 1.07
3 Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation. Int J Tissue React 1990 1.07
4 Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. Acta Haematol 1993 1.05
5 Mechanisms of tumour cell destruction by PMA-activated human neutrophils. Immunology 1983 0.97
6 Inhibition of neutrophil cytolysin production by target cells. Blood 1986 0.96
7 Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. Gut 1990 0.94
8 Defective antibody-dependent tumour cell lysis by neutrophils from cancer patients. Clin Exp Immunol 1989 0.92
9 Relationship between antibody-dependent tumour cell lysis and primary granule exocytosis by human neutrophils. Clin Exp Immunol 1987 0.91
10 Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. Curr Cancer Drug Targets 2012 0.89
11 Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation 1991 0.88
12 Neutrophil-induced depletion of adenosine triphosphate in target cells: evidence for a hypochlorous acid-mediated process. J Lab Clin Med 1988 0.87
13 Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. Blood 1987 0.86
14 Effects of ascorbic acid on neutrophil locomotion. Int Arch Allergy Appl Immunol 1980 0.85
15 Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates. Immunology 1987 0.85
16 A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. Curr Cancer Drug Targets 2012 0.85
17 Neutrophil-mediated cellular cytotoxicity triggered by immobilized aggregated IgG: an in vitro model of cell injury during immune complex diseases. J Clin Immunol 1984 0.84
18 Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. Scand J Immunol 1983 0.84
19 Down-regulation of K cell activity by neutrophils. Blood 1985 0.84
20 Evidence for a reversible functional state of neutrophil chemotactic deactivation. Int Arch Allergy Appl Immunol 1980 0.84
21 Serum-associated inhibition of neutrophil Fc receptors in cancer patients. J Natl Cancer Inst 1981 0.84
22 Erythrocyte lysis by PMA-triggered neutrophil polymorphonuclears: evidence for an hypochlorous acid-dependent process. Immunology 1985 0.84
23 Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. Cancer 2001 0.84
24 Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid. Br J Dermatol 1980 0.83
25 High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. Haematologica 1997 0.83
26 Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears. Exp Hematol 1982 0.83
27 Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. Int J Lab Hematol 2009 0.83
28 Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. J BUON 2011 0.82
29 Neutrophil functions in acne conglobata. Dermatologica 1979 0.82
30 In vitro effects of synthetic chemotactic peptides on neutrophil function. Int Arch Allergy Appl Immunol 1980 0.82
31 Stimulation of neutrophil chemotaxis, adhesiveness, phagocytosis, and hexose monophosphate shunt activity by N-(2-mercaptopropionyl)glycine. Res Exp Med (Berl) 1981 0.82
32 Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. Curr Cancer Drug Targets 2012 0.82
33 Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. Curr Cancer Drug Targets 2012 0.82
34 Neutropenia and impaired neutrophil function in glycogenosis type Ib. J Inherit Metab Dis 1984 0.81
35 Ultrasonography-guided endoscopic stent placement for malignant biliary obstruction: a preliminary report of four cases. Endoscopy 2004 0.81
36 A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. Exp Hematol 1983 0.80
37 The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer. Cancer Immunol Immunother 1999 0.80
38 Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease. Acta Hepatogastroenterol (Stuttg) 1978 0.80
39 Reversal by cimetidine of histamine-induced inhibition of true chemotaxis in neutrophil polymorphonuclears. Res Exp Med (Berl) 1980 0.80
40 Anticancer vaccination strategies. Ann Oncol 2004 0.80
41 Extracellular cytotoxicity by phagocytosing polymorphonuclear neutrophilic leukocytes: enhancement by a chemotactic stimulus. Exp Hematol 1985 0.79
42 Erythrocyte lysis by monocytes: investigations on the mechanism and role of the target cell hydrogen peroxide catabolizing pathways. J Clin Lab Immunol 1987 0.79
43 High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma. Int J Oncol 2000 0.79
44 High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule. Br J Cancer 1997 0.78
45 Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. Leuk Res 1995 0.78
46 Modulation of neutrophil Fc and C3b receptors. Relationship with the phagocytic process and activation of the respiratory burst. Inflammation 1983 0.78
47 Platelets as inhibitory cells in neutrophil-mediated cytolysis. J Lab Clin Med 1989 0.78
48 [Ultrasound-guided endoscopic drainage, without radiological examination, in patients with neoplastic biliary obstruction. Preliminary results]. Minerva Chir 2004 0.77
49 Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br J Cancer 2005 0.77
50 Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. Res Exp Med (Berl) 1980 0.77
51 High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. Cancer Genet Cytogenet 1997 0.77
52 Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. Thromb Haemost 1989 0.77
53 Defective neutrophil mobilization to skin chambers in cancer patients. J Cancer Res Clin Oncol 1984 0.76
54 IgA-related defective neutrophil chemotaxis in ulcerative colitis. Boll Ist Sieroter Milan 1978 0.76
55 MOF induced by meningococcal sepsis: successful outcome after intensive multidisciplinary approaches. Transfus Apher Sci 2005 0.76
56 Effects of ascorbic acid on neutrophil function. Studies on normal and chronic granulomatous disease neutrophils. Acta Vitaminol Enzymol 1982 0.76
57 Disorders of neutrophil function in children with recurrent pyogenic infections. Med Microbiol Immunol 1982 0.75
58 Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF. J Clin Oncol 1999 0.75
59 Chemotactic peptide enhancement of PMA triggered monocyte cytotoxicity. Clin Exp Immunol 1984 0.75
60 Neutrophil-mediated antibody-dependent cellular cytotoxicity against erythrocytes. Mechanisms of target cell destruction. Clin Exp Immunol 1983 0.75
61 Prevention of neutrophil chemotactic deactivation by ascorbic acid. Br J Exp Pathol 1980 0.75
62 Interference of target cell catalase with an early step of the neutrophil cytolytic pathway. Clin Exp Immunol 1986 0.75
63 High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer. N Engl J Med 2000 0.75
64 [Platelet preservation for blood transfusion. Effects of dimethyl sulfoxide (DMSO) on platelet function in vitro]. Riv Emoter Immunoematol 1974 0.75
65 Expression of cytolytic functions in HL-60 leukaemic cells after induction of polymorphonuclear leukocyte differentiation. Blut 1986 0.75
66 [Effects in vitro of lidocaine hydrochloride on leukocytes. Morphological and functional aspects]. Boll Soc Ital Biol Sper 1977 0.75
67 Repeated staphylococcal pyoderma in two siblings with defective neutrophil bacterial killing. Dermatologica 1980 0.75
68 [Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. II. Specimens mounted in neutral resin]. Boll Soc Ital Biol Sper 1976 0.75
69 [Vitamin C and phagocytic system: present status and perspectives (author's transl)]. Acta Vitaminol Enzymol 1979 0.75
70 Variant Philadelphia chromosome translocations are frequently associated with additional structural abnormalities. Cancer Genet Cytogenet 1994 0.75
71 Myeloperoxidase-deficient neutrophils in chronic myelocytic leukemia. Haematologica 1978 0.75
72 [Problems related to the NBT test in the diagnosis of infectious diseases]. Boll Soc Ital Biol Sper 1977 0.75
73 Enhancement of the in vitro colony-forming capacity of human T lymphocytes induced by levamisole. Thymus 1982 0.75
74 Hyperimmunoglobulinemia E syndrome. Arch Dermatol 1978 0.75
75 Neutrophil chemotaxis: physiology and pathology. Haematologica 1978 0.75
76 Naturally-occurring cellular cytotoxicity mediated by neutrophil polymorphonuclears: requirements for the target cell lysis. J Clin Lab Immunol 1984 0.75
77 Cytolysis mediated by phagocytosing neutrophils. Influence of the presence of an alternative target cell population. J Clin Lab Immunol 1988 0.75
78 Thrombocytosis in subjects with chronic myelocytic leukemia in blastic metamorphosis. Clinical remarks and therapeutic considerations (5 case reports). Haematologica 1982 0.75
79 Effects of N-(2-mercaptopropionyl) glycine on neutrophil locomotion. Int Arch Allergy Appl Immunol 1981 0.75
80 [Defective neutrophil chemotaxis in patients with recurrent infections (author's transl)]. Haematologica 1980 0.75
81 [Changes in granulocytic alkaline phosphatase activity as a function of nuclear segmentation]. Boll Soc Ital Biol Sper 1976 0.75
82 [Distribution of alkaline phosphatase in granulocytes: theoretical and methodological implications]. Boll Soc Ital Biol Sper 1976 0.75
83 Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation. Exp Hematol 1979 0.75
84 Suppression of lymphokine-activated killer (LAK) cell function by neutrophil polymorphonuclear leukocytes. J Clin Lab Immunol 1991 0.75
85 Monocyte-derived macrophages as helper cells in monocyte-mediated cytolysis. Br J Haematol 1988 0.75
86 Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide, and cisplatin (CEP). Am J Clin Oncol 1997 0.75
87 Italian Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group Trials. GROCTA Trials. Recent Results Cancer Res 1998 0.75
88 Restoration of defective EAG-rosetting capacity of cancer patient neutrophils by levamisole. Cancer 1985 0.75
89 [Platelet dynamics in splenectomized patients]. Riv Emoter Immunoematol 1974 0.75
90 [Morphological and functional aspects of blood platelets preserved in DMSO at -180 degrees C]. Riv Emoter Immunoematol 1976 0.75
91 [Physiopathology of neutrophilic granulocytes (author's transl)]. Haematologica 1979 0.75
92 Repeated skin infections as a manifestation of lupus erythematosus. Arch Dermatol 1982 0.75
93 [Lymphedema of the lower limbs secondary to neoplastic lymphangitis caused by mucin-producing adenocarcinoma of the stomach. 2 case reports]. Minerva Chir 1988 0.75
94 Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. Cancer Genet Cytogenet 1998 0.75
95 Defective neutrophil chemotaxis and bactericidal power in a child with hyperimmunoglobulinemia E. Eur J Pediatr 1979 0.75
96 PHA-induced neutrophil-mediated cytotoxicity. J Clin Lab Immunol 1983 0.75
97 [Distribution of acid phosphatase activity in white blood cells]. Boll Soc Ital Biol Sper 1976 0.75
98 [Essential thrombocytemia, Hematological, clinical and dynamic aspects in 5 cases]. Haematologica 1972 0.75
99 In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage. Tumori 1979 0.75
100 Neutrophil-mediated cellular cytotoxicity induced by zymosan-activated serum. J Clin Lab Immunol 1984 0.75
101 Effector-target co-aggregation as a crucial step in the neutrophil-mediated tumour cell lysis. J Clin Lab Immunol 1989 0.75
102 Phagocytosis-dependent neutrophil-mediated extracellular cytotoxicity against different target cells. Acta Haematol 1984 0.75
103 Normal polymorphonuclear neutrophil function in a case of glycogen storage disease type Ib. Eur J Pediatr 1990 0.75
104 Cellular cytotoxicity mediated by granule-depleted neutrophil cytoplasts. Blut 1985 0.75
105 [Endoscopic palliation of inoperable hilar biliary carcinoma with self-expanding metal stents]. Minerva Chir 2004 0.75
106 Small-bowel polyps in Peutz-Jeghers syndrome: diagnosis by wireless capsule endoscopy. Endoscopy 2004 0.75
107 [Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. I. Specimens mounted in neutral resin]. Boll Soc Ital Biol Sper 1976 0.75
108 Identification of mouse bone marrow colony growth in agar-cultures by the nitroblue tetrazolium dye. Boll Ist Sieroter Milan 1978 0.75
109 [Chronic hypomegakaryocytic thrombocytopenia. Report on 3 cases]. Riv Emoter Immunoematol 1975 0.75
110 Target cell lysis mediated by concanavalin A-triggered human neutrophils. Blut 1984 0.75
111 [Evaluation of the response to hypo osmolarity of platelets preserved in DMSO at 180 degrees C]. Boll Soc Ital Biol Sper 1975 0.75
112 [The Fisher-Evans syndrome. Report on 5 cases]. Riv Emoter Immunoematol 1975 0.75
113 Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization. Leukemia 1995 0.75
114 [Checking of various hemostatic indices in patients with vascular diseases before and after treatment with inhibitors of platelet adhesiveness]. Minerva Cardioangiol 1975 0.75
115 Buckley's syndrome. Br J Dermatol 1978 0.75
116 A simple acid-precipitation test for rapid screening of monoclonal gammopathies. Quad Sclavo Diagn 1979 0.75
117 Immunopathological studies on a case of Sweet's syndrome. Dermatologica 1981 0.75
118 Role of hypochlorous acid and chloramines in the extracellular cytolysis by neutrophil polymorphonuclear leukocytes. J Clin Lab Immunol 1986 0.75
119 Duplication of the der(13)t(12;13)(p13;q14) in chronic myelomonocytic leukemia. Haematologica 1997 0.75
120 [Essential thrombocythemia. Report of personal cases and review of the literature]. Recenti Prog Med 1977 0.75
121 Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. Leuk Res 1997 0.75
122 [Semiquantitative evaluation of leukocyte acid phosphatase]. Boll Soc Ital Biol Sper 1976 0.75
123 Stimulation of neutrophil locomotion by inosiplex. Int Arch Allergy Appl Immunol 1980 0.75
124 Trisomy 8 detection in Ph+ CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques. Cancer Genet Cytogenet 1994 0.75
125 Lazy leukocyte syndrome. Blut 1979 0.75
126 Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. Oncology 2001 0.75
127 Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. J BUON 2010 0.75
128 [Cytochemical semiquantitative evaluation of peroxidase activity in blood cells. Method]. Boll Soc Ital Biol Sper 1977 0.75
129 Extracellular cytolysis by leukaemic blast cells. Br J Haematol 1984 0.75
130 [Platelet preservation for blood transfusion. Morphological ultrastructural evaluation of platelets exposed to various concentrations of dimethyl sulfoxide (DMSO)]. Riv Emoter Immunoematol 1974 0.75
131 [Studies on the place of destruction of platelets in chronic idiopathic thrombocytopenia]. Riv Emoter Immunoematol 1975 0.75
132 Neutrophil function in patients with lymphoproliferative disorders. Haematologica 1983 0.75
133 Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. Oncology 2000 0.75
134 [Granulocyte acid phosphatase activity during the course of chronic myeloid leukemia and Hodgkin's disease]. Boll Soc Ital Biol Sper 1977 0.75
135 Defective neutrophil function in an adult patient with repeated infections. Haematologica 1980 0.75
136 [Hereditary macrothrombocytic thrombocytopenia. Description of a family carrying this anomaly]. Haematologica 1972 0.75